A2RR34:BVMF
Arrowhead Pharmaceuticals Inc
R$54.48
0.00%
(0.00) 1D
Sep 9, 10:39:08 AM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A2RR34...
Mkt. cap
11.70B
Avg. vol.
309.00
Volume
0.00
52-wk high
R$59.95
52-wk low
R$18.84
Shares outstanding
141.25M
No. of employees
711
Mkt. cap
11.70B
Avg. vol.
309.00
Volume
0.00
52-wk high
R$59.95
52-wk low
R$18.84
Shares outstanding
141.25M
No. of employees
711
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com